Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 13(2); Dec 2022
Review Article
6
Autoimmune Nodopathies
Hyun Ji Lyou, Ha Young Shin
J Mult Scler Neuroimmunol. 2022;13(2):23-29.   Published online December 31, 2022
PDFPDF    
Case Reports
7
Favorable Response to Rituximab in a Patient with Recurrent Primary Angiitis of the Central Nervous System: A Case Report and Literature Review
Tae Young Kim, Yong Jin Kim, Min Kim, Jae Hyun Jeon, Hyun-Mi Park, Dong Hoon Shin, Jiwon Yang
J Mult Scler Neuroimmunol. 2022;13(2):30-34.   Published online December 31, 2022
PDFPDF    
8
A Case of Parkinsonism after Asymptomatic COVID-19 Infection Treated with High-Dose Corticosteroid
Yu-Jin Kang, Ga Eun Koo, Yi-Seul Choo, Moonho Won, Chan-Young Park
J Mult Scler Neuroimmunol. 2022;13(2):35-38.   Published online December 31, 2022
PDFPDF    
Neuroimage
9
Unilateral Dominant Pachymeningitis in ANCA-associated Vasculitis
Euihyun Sung, Young Seo Kim
J Mult Scler Neuroimmunol. 2022;13(2):39-40.   Published online December 31, 2022
PDFPDF    

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

  • 4,803 Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
    1,276 Rituximab Treatment for Neuroimmunologic Disorders
    1,235 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
    1,078 Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
    989 New Therapeutic Agents in Myasthenia Gravis

    +more

    Cited By
    1
    Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

    +more

    • GoogleScholar
    • Similarity Check
    • Crossref Cited-by Linking
    • CrossMark
    • Funder Registry
    • ORCID


Editorial Office
Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153   E-mail: icandr@cau.ac.kr                

Copyright © 2024 by Korean Society of Neuroimmunology.

Developed in M2PI